Home › Funds › Venrock Adviser, LLC › MAZE

Venrock Adviser, LLC position in MAZE

MAZE THERAPEUTICS INC · Health Care

Venrock Adviser, LLC reported holding 1,602,034 shares of MAZE (MAZE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$47.8M, representing 1.45% of its reported portfolio and ranking #14 among its reported holdings. Venrock Adviser, LLC has disclosed MAZE holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.60M sh
Reported value held$47.80M
Portfolio Weight1.45%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's MAZE position evolved

Venrock Adviser, LLC first disclosed a stake in MAZE in Q3 2025 at 1,230,769 shares (US$31.9M). The position peaked in Q4 2025 at 1,548,569 shares, worth US$64.2M. Across 4 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,602,034 shares valued at US$47.8M. Notable position changes include a 26% increase in Q4 2025 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.23M $31.91M New
Q4 2025 1.55M $64.16M Add
Q1 2026 1.60M $47.82M Add
Q2 2026 1.60M $47.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MAZE and 13F data

MAZE (MAZE THERAPEUTICS INC) is a Health Care company. 74 other funds we track also report a position in MAZE — the largest reported positions include Frazier Life Sciences Management, L.P. (US$150.2M), TRV GP IV, LLC (US$133.5M), ARCH Venture Management, LLC (US$123.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MAZE

All MAZE fund holders →

FAQ

How long has Venrock Adviser, LLC held MAZE?

Venrock Adviser, LLC has disclosed MAZE holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Venrock Adviser, LLC's current position in MAZE?

As of Q2 2026, Venrock Adviser, LLC holds 1.60M shares of MAZE (MAZE THERAPEUTICS INC), valued at $47.80M, representing 1.45% of its reported portfolio and ranking #14.

Has Venrock Adviser, LLC been buying or selling MAZE?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in MAZE. The position peaked in Q4 2025 at 1.55M shares.

Which other funds hold MAZE?

Other major institutional holders of MAZE include Frazier Life Sciences Management, L.P., TRV GP IV, LLC, ARCH Venture Management, LLC, among 74 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.